Determining Minimal Residual Disease Using ctDNA Deep Sequencing
Determining Minimal Residual Disease Using ctDNA Deep Sequencing
Recruiting · NCT07660627 · Registry updated 2026-06-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Determining Minimal Residual Disease Using ctDNA Deep Sequencing | Digestive System Diseases, Digestive System Neoplasms, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, endocrine system disorder, esophageal adenocarcinoma, gastric cancer, gastric neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, stomach disorder | Recruiting | Not applicable | 2026-06-24 | NCT07660627 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Masaryk Memorial Cancer Institute | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Masaryk Memorial Cancer Institute | Brno | Czechia | 10 |